{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:03:20Z","timestamp":1792839800862,"version":"4.5.0"},"reference-count":304,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Endocrine disorders are associated with various tachyarrhythmias, including atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation (VF), and bradyarrhythmias. Along with underlying arrhythmia substrate, electrolyte disturbances, glucose, and hormone levels, accompanying endocrine disorders contribute to development of arrhythmia. Arrhythmias may be life-threatening, facilitate cardiogenic shock development and increase mortality. The knowledge on the incidence of tachy- and bradyarrhythmias, clinical and prognostic significance as well as their management is limited; it is represented in observational studies and mostly in case reports on management of challenging cases. It should be also emphasized, that the topic is not covered in detail in current guidelines. Therefore, cardiologists and multidisciplinary teams participating in care of such patients do need the evidence-based, or in case of limited evidence expert-opinion based recommendations, how to treat arrhythmias using contemporary approaches, prevent their complications and recurrence in patients with endocrine disorders. In recognizing this close relationship between endocrine disorders and arrhythmias, the European Heart Rhythm Association (EHRA) convened a Task Force, with representation from Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLAECE), with the remit of comprehensively reviewing the available evidence and publishing a joint consensus document on endocrine disorders and cardiac arrhythmias, and providing up-to-date consensus recommendations for use in clinical practice.<\/jats:p>","DOI":"10.1093\/europace\/euy051","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T02:52:47Z","timestamp":1521168767000},"page":"895-896","source":"Crossref","is-referenced-by-count":32,"title":["European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)"],"prefix":"10.1093","volume":"20","author":[{"given":"Bulent","family":"Gorenek","sequence":"first","affiliation":[{"name":"Eskisehir Osmangazi University, Eskisehir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorge-Andrei","family":"Dan","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy \u201cCarol Davila\u201d, Colentina University Hospital, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire Trousseau et Universit\u00e9 Fran\u00e7ois Rabelais, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Fenelon","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[{"name":"Renmin Hospital of Wuhan University, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulmira","family":"Kudaiberdieva","sequence":"additional","affiliation":[{"name":"Adana, Turkey"},{"name":"Center for Postgraduate Education and Research, Bishkek, Kyrgyzstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Mahajan","sequence":"additional","affiliation":[{"name":"The University of Adelaide, Lyell McEwin Hospital, Royal Adelaide Hospital and SAHMRI, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[{"name":"School of Medicine, Belgrade University; Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan David","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Clinica CardioVid, Medell\u00edn, Antioquia, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A","family":"Vos","sequence":"additional","affiliation":[{"name":"Umc Utrecht, Utrecht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Marin","sequence":"additional","affiliation":[{"name":"HU Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Blomstrom-Lundqvist","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"St Thomas\u2019 Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Bongiorni","sequence":"additional","affiliation":[{"name":"Santa Chiara University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sciaraffia","sequence":"additional","affiliation":[{"name":"Uppsala University Hospital, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Cosedis","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lewalter","sequence":"additional","affiliation":[{"name":"Peter Osypka Heart Center, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Fuwai Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswaldo","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Hospital Clinica Bblica, San Jose, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Fuenmayor","sequence":"additional","affiliation":[{"name":"Electrophysiology and Arrhythmia Section, Cardiovascular Research Institute, University Hospital of The Andes, Avenida 16 de Septiembre, M\u00e9rida 5101, Venezuela"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"2026080923265475000_euy051-B1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1748-1716.2007.01753.x","article-title":"Role of slow delayed rectifier K-current in QT prolongation in the alloxan-induced diabetic rabbit heart","volume":"192","author":"Lengyel","year":"2008","journal-title":"Acta Physiol"},{"key":"2026080923265475000_euy051-B2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/CIRCRESAHA.116.303975","article-title":"Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels","volume":"116","author":"Ballou","year":"2015","journal-title":"Circ Res"},{"key":"2026080923265475000_euy051-B3","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/europace\/eux068","article-title":"The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies: a report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC)","volume":"19","author":"Boriani","year":"2017","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCULATIONAHA.116.025312","article-title":"Atrial fibrillation and ventricular arrhythmias: sex differences in electrophysiology, epidemiology, clinical presentation, and clinical outcome","volume":"135","author":"Gilles","year":"2017","journal-title":"Circulation"},{"key":"2026080923265475000_euy051-B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1096\/fj.12-218230","article-title":"Regulation of ion channels by the serum and glucocortoid inducible kinase SGK1","volume":"27","author":"Lang","year":"2013","journal-title":"FASEB J"},{"key":"2026080923265475000_euy051-B6","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.2337\/dc17-S012","article-title":"Cardiovascular disease and risk management","volume":"40","author":"American Diabetes A. 9","year":"2017","journal-title":"Diabetes Care"},{"key":"2026080923265475000_euy051-B7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.CIR.102.9.1014","article-title":"Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry","volume":"102","author":"Malmberg","year":"2000","journal-title":"Circulation"},{"key":"2026080923265475000_euy051-B8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jamacardio.2016.3030","article-title":"Prognostic implications of biomarker assessments in patients with type 2 diabetes at high cardiovascular risk: a secondary analysis of a randomized clinical trial","volume":"1","author":"Scirica","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026080923265475000_euy051-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2848759","article-title":"Molecular and electrophysiological mechanisms underlying cardiac arrhythmogenesis in diabetes mellitus","volume":"2016","author":"Tse","year":"2016","journal-title":"J Diabetes Res"},{"key":"2026080923265475000_euy051-B10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4239\/wjd.v7.i3.45","article-title":"Role of diabetes in heart rhythm disorders","volume":"7","author":"Koektuerk","year":"2016","journal-title":"World J Diabetes"},{"key":"2026080923265475000_euy051-B11","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.292.20.2495","article-title":"Trends in cardiovascular complications of diabetes","volume":"292","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"2026080923265475000_euy051-B12","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0735-1097(02)02044-2","article-title":"The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men","volume":"40","author":"Cho","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B13","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/S0140-6736(99)04383-4","article-title":"Diabetes as a risk factor for sudden death","volume":"354","author":"Balkau","year":"1999","journal-title":"Lancet"},{"key":"2026080923265475000_euy051-B14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amjcard.2010.08.049","article-title":"A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)","volume":"107","author":"Chamberlain","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B15","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11606-010-1340-y","article-title":"Diabetes mellitus, glycemic control, and risk of atrial fibrillation","volume":"25","author":"Dublin","year":"2010","journal-title":"J Gen Intern Med"},{"key":"2026080923265475000_euy051-B17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.amjcard.2014.07.045","article-title":"Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)","volume":"114","author":"Fatemi","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"2026080923265475000_euy051-B20","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/CIRCULATIONAHA.107.744466","article-title":"Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study","volume":"117","author":"Watanabe","year":"2008","journal-title":"Circulation"},{"key":"2026080923265475000_euy051-B21","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacc.2012.06.030","article-title":"Type 2 diabetes mellitus and risk of incident atrial fibrillation in women","volume":"60","author":"Schoen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B22","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehp055","article-title":"Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study","volume":"30","author":"Du","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.amjcard.2007.10.025","article-title":"Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial)","volume":"101","author":"Aksnes","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/14779072.2016.1179581","article-title":"Lifestyle management to prevent and treat atrial fibrillation","volume":"14","author":"Gallagher","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026080923265475000_euy051-B25","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/dc09-0939","article-title":"Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation","volume":"32","author":"Nichols","year":"2009","journal-title":"Diabetes Care"},{"key":"2026080923265475000_euy051-B26","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B27","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.116.026693","article-title":"Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration","volume":"135","author":"Freedman","year":"2017","journal-title":"Circulation"},{"key":"2026080923265475000_euy051-B28","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/europace\/eux177","article-title":"Screening for Atrial Fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Societad Latinoamericana de Estimulation Cardiaca y Electrofisiologia (SOLAECE)","volume":"19","author":"Mairesse","year":"2017","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijcard.2014.08.105","article-title":"Diabetes mellitus and risk of sudden cardiac death: a systematic review and meta-analysis","volume":"177","author":"Zaccardi","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026080923265475000_euy051-B30","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/europace\/euv214","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Anselmino","year":"2015","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2016.03.069","article-title":"Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: who benefits and who does not? Data from German ablation registry","volume":"214","author":"Bogossian","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080923265475000_euy051-B32","doi-asserted-by":"crossref","first-page":"22.","DOI":"10.1111\/j.1540-8167.2008.01275.x","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy","volume":"20","author":"Forleo","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265475000_euy051-B33","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/eurheartj\/ehi376","article-title":"Diabetes, glucose level, and risk of sudden cardiac death","volume":"26","author":"Jouven","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2298\/SARH0206189P","article-title":"[Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation]","volume":"130","author":"Potpara","year":"2002","journal-title":"Srp Arh Celok Lek"},{"key":"2026080923265475000_euy051-B35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00592-009-0157-9","article-title":"Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study","volume":"47","author":"Kucharska-Newton","year":"2010","journal-title":"Acta Diabetol"},{"key":"2026080923265475000_euy051-B36","doi-asserted-by":"crossref","first-page":"51.","DOI":"10.1186\/s12872-016-0231-5","article-title":"Diabetes, glucose tolerance, and the risk of sudden cardiac death","volume":"16","author":"Eranti","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"2026080923265475000_euy051-B37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1056-8727(02)00206-4","article-title":"Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study","volume":"17","author":"Cardoso","year":"2003","journal-title":"J Diabetes Complications"},{"key":"2026080923265475000_euy051-B38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1540-8159.2007.00849.x","article-title":"Relationship between abnormal microvolt T-wave alternans and poor glycemic control in type 2 diabetic patients","volume":"30","author":"Molon","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/oxfordjournals.qjmed.a068054","article-title":"The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability","volume":"61","author":"O'Brien","year":"1986","journal-title":"Q J Med"},{"key":"2026080923265475000_euy051-B40","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.CIR.90.2.878","article-title":"Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study","volume":"90","author":"Tsuji","year":"1994","journal-title":"Circulation"},{"key":"2026080923265475000_euy051-B41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"2026080923265475000_euy051-B42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0002-9149(00)00920-6","article-title":"Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)","volume":"86","author":"Singh","year":"2000","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B43","doi-asserted-by":"crossref","first-page":"28.","DOI":"10.1186\/1475-2840-13-28","article-title":"The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus","volume":"13","author":"Cherney","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"2026080923265475000_euy051-B44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2007.03.106","article-title":"Heart rate variability and heart rate turbulence in patients with type 2 diabetes mellitus with versus without cardiac autonomic neuropathy","volume":"100","author":"Balc\u0131o\u011flu","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B45","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1540-8167.2011.02082.x","article-title":"Heart rate turbulence can predict cardiac mortality following myocardial infarction in patients with diabetes mellitus","volume":"22","author":"Miwa","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265475000_euy051-B46","doi-asserted-by":"crossref","first-page":":1073","DOI":"10.5114\/aoms.2014.47819","article-title":"Heart rate turbulence in patients with poorly controlled diabetes mellitus type 2","volume":"10","author":"Bissinger","year":"2014","journal-title":"Arch Med Sci"},{"key":"2026080923265475000_euy051-B47","first-page":"1601","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1540-8159.2006.00298.x","article-title":"Suboptimal glycemic control, independently of QT interval duration, is associated with increased risk of ventricular arrhythmias in a high-risk population","volume":"29","author":"Chen-Scarabelli","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1464-5491.2010.03154.x","article-title":"Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries","volume":"28","author":"Secrest","year":"2011","journal-title":"Diabet Med"},{"key":"2026080923265475000_euy051-B50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4158\/EP09260.CR","article-title":"Confirmation of hypoglycemia in the \u201cdead-in-bed\u201d syndrome, as captured by a retrospective continuous glucose monitoring system","volume":"16","author":"Tanenberg","year":"2010","journal-title":"Endocr Pract"},{"key":"2026080923265475000_euy051-B51","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients","volume":"367","author":"NICE-SUGAR Study Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B52","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/eurheartj\/eht332","article-title":"Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial","volume":"34","author":"ORIGIN Trial Investigators","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B53","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"Gerstein","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B54","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B55","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/db13-0468","article-title":"Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk","volume":"63","author":"Chow","year":"2014","journal-title":"Diabetes"},{"key":"2026080923265475000_euy051-B56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/152091503763816427","article-title":"Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring","volume":"5","author":"Hay","year":"2003","journal-title":"Diabetes Technol Ther"},{"key":"2026080923265475000_euy051-B57","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.2337\/db13-0216","article-title":"Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation","volume":"62","author":"Reno","year":"2013","journal-title":"Diabetes"},{"key":"2026080923265475000_euy051-B58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.117.09259","article-title":"Risk of cardiovascular events in patients with diabetes mellitus on beta-blockers","volume":"70","author":"Tsujimoto","year":"2017","journal-title":"Hypertension"},{"key":"2026080923265475000_euy051-B59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacc.2007.04.060","article-title":"Cardiovascular protection using beta-blockers: a critical review of the evidence","volume":"50","author":"Bangalore","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B60","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.2337\/dc17-S009","article-title":"Glycemic targets","volume":"40","author":"American Diabetes A. 6","year":"2017","journal-title":"Diabetes Care"},{"key":"2026080923265475000_euy051-B61","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B63","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.2337\/dc17-S011","article-title":"Pharmacologic approaches to glycemic treatment","volume":"40","author":"American Diabetes A. 8","year":"2017","journal-title":"Diabetes Care"},{"key":"2026080923265475000_euy051-B64","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B65","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B66","author":"Raz"},{"key":"2026080923265475000_euy051-B67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-016-0356-y","article-title":"Cardovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis","volume":"15","author":"Sonesson","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"2026080923265475000_euy051-B68","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S2213-8587(16)00052-8","article-title":"Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"4","author":"Wu","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026080923265475000_euy051-B69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40119-016-0069-z","article-title":"Sodium-glucose cotransporter 2 (SGLT2)inhibiotrs and cardiovascular disease: a systematic review","volume":"5","author":"Kalra","year":"2016","journal-title":"Cardiol Ther"},{"key":"2026080923265475000_euy051-B70","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B71","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B72","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"ADVANCE Collaborative Group","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B74","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"NICE-SUGAR Study Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B75","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0735-1097(01)01731-4","article-title":"Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes","volume":"39","author":"Chen","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B76","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.cardfail.2014.10.003","article-title":"Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model","volume":"20","author":"Zhang","year":"2014","journal-title":"J Card Fail"},{"key":"2026080923265475000_euy051-B77","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0735-1097(86)80279-0","article-title":"Atrioventricular block complicating amiodarone-induced hypothyroidism in a patient with pre-excitation and rate-dependent bilateral bundle branch block","volume":"7","author":"Mangiardi","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B78","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.biocel.2010.07.013","article-title":"Cardiac arrhythmias and thyroid dysfunction: a novel genetic link","volume":"42","author":"Purtell","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"2026080923265475000_euy051-B79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12020-014-0495-4","article-title":"Activating autoantibodies to the \u03b21\/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism","volume":"49","author":"Galloway","year":"2015","journal-title":"Endocrine"},{"key":"2026080923265475000_euy051-B80","doi-asserted-by":"crossref","first-page":"e7895","DOI":"10.1136\/bmj.e7895","article-title":"The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study","volume":"345","author":"Selmer","year":"2012","journal-title":"BMJ"},{"key":"2026080923265475000_euy051-B81","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","article-title":"Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study","volume":"164","author":"Frost","year":"2004","journal-title":"Arch Intern Med"},{"key":"2026080923265475000_euy051-B82","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"key":"2026080923265475000_euy051-B83","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factors for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"2026080923265475000_euy051-B84","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1067\/mhj.2001.119370","article-title":"Subclinical hypothyroidism as a risk factor for atrial fibrillation","volume":"142","author":"Auer","year":"2001","journal-title":"Am Heart J"},{"key":"2026080923265475000_euy051-B85","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archinte.167.9.928","article-title":"Association between free thyroxine concentration and atrial fibrillation","volume":"167","author":"Gammage","year":"2007","journal-title":"Arch Intern Med"},{"key":"2026080923265475000_euy051-B86","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026080923265475000_euy051-B87","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1001\/archinte.168.20.2219","article-title":"High-normal thyroid function and risk of atrial fibrillation","volume":"168","author":"Heeringa","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026080923265475000_euy051-B88","article-title":"Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update","author":"Floriani","year":"2017","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B89","first-page":"190","article-title":"European Heart Rhythm Association (EHRA)\/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)","volume-title":"Europace","author":"Gorenek","year":"2017"},{"key":"2026080923265475000_euy051-B90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2013.10.012","article-title":"Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study)","volume":"167","author":"Kim","year":"2014","journal-title":"Am Heart J"},{"key":"2026080923265475000_euy051-B91","doi-asserted-by":"crossref","first-page":"e66711","DOI":"10.1371\/journal.pone.0066711","article-title":"Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study","volume":"8","author":"Brandt","year":"2011","journal-title":"PLoS One"},{"key":"2026080923265475000_euy051-B92","doi-asserted-by":"crossref","first-page":"e51.","DOI":"10.1016\/j.amjmed.2015.06.012","article-title":"Hypothyroidism was 300% more frequent that hyperthyroidism in patients with atrial fibrillation enrolled over 10 years","volume":"128","author":"Chauhan","year":"2015","journal-title":"Am J Med"},{"key":"2026080923265475000_euy051-B93","first-page":"427","article-title":"Subclinical hypothyroidism might increase the risk of postoperative atrial fibrillation after aortic valve replacement","volume":"64","author":"Martinez-Comendador","year":"2016","journal-title":"Thorac Cardiovasc Surg"},{"key":"2026080923265475000_euy051-B94","doi-asserted-by":"crossref","first-page":"e9.","DOI":"10.1016\/j.amjmed.2014.10.006","article-title":"Thyroid heart disease should include the coincidental association of hypothyroidism and atrial fibrillation","volume":"128","author":"Jolobe","year":"2015","journal-title":"Am J Med"},{"key":"2026080923265475000_euy051-B95","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jocs.12513","article-title":"Preoperative hypothyroidism is a risk factor for postoperative atrial fibrillation in cardiac surgical patients","volume":"30","author":"Worku","year":"2015","journal-title":"J Card Surg"},{"key":"2026080923265475000_euy051-B96","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/CIRCEP.113.000502","article-title":"Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats","volume":"6","author":"Zhang","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265475000_euy051-B97","first-page":"710.","article-title":"Subclinical hypothyroidism: an overlooked cause of atrial fibrillation?","volume":"5","author":"Kolettis","year":"2012","journal-title":"J Atr Fibrillation"},{"key":"2026080923265475000_euy051-B98","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0002-9343(82)90850-6","article-title":"Management of atrial fibrillation in the post-thyrotoxic state","volume":"72","author":"Nakazawa","year":"1982","journal-title":"Am J Med"},{"key":"2026080923265475000_euy051-B99","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2169\/internalmedicine.50.6135","article-title":"Risk factors for persistent atrial fibrillation following successful hyperthyroidism treatment with radioiodine therapy","volume":"50","author":"Zhou","year":"2011","journal-title":"Intern Med"},{"key":"2026080923265475000_euy051-B100","doi-asserted-by":"crossref","first-page":"e0122388.","DOI":"10.1371\/journal.pone.0122388","article-title":"Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine","volume":"10","author":"Tsymbaliuk","year":"2015","journal-title":"PLoS One"},{"key":"2026080923265475000_euy051-B101","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/lary.25687","article-title":"Impact of thyroidectomy on cardiac manifestations of Graves' disease","volume":"126","author":"Gauthier","year":"2016","journal-title":"Laryngoscope"},{"key":"2026080923265475000_euy051-B102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003495-198427050-00003","article-title":"Use of beta-adrenoreceptor blocking drugs in hyperthyroidism","volume":"27","author":"Feely","year":"1984","journal-title":"Drugs"},{"key":"2026080923265475000_euy051-B103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000658-200101000-00010","article-title":"Oxygen consumption in patients with hyperthyroidism before and after treatment with beta-blockade vs. thyrostatic treatment: a prospective randomized study","volume":"233","author":"Jansson","year":"2001","journal-title":"Ann Surg"},{"key":"2026080923265475000_euy051-B104","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-2007-971065","article-title":"Cardiovascular collapse associated with beta-blockade in thyroid storm","volume":"115","author":"Dalan","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026080923265475000_euy051-B105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0167-5273(87)90269-5","article-title":"High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atria1 fibrillation","volume":"16","author":"Nakazawa","year":"1987","journal-title":"Int J Cardiol"},{"key":"2026080923265475000_euy051-B106","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/euhj.1999.1956","article-title":"Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation","volume":"21","author":"Nakazawa","year":"2000","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B107","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.amjcard.2008.10.019","article-title":"Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation","volume":"103","author":"Siu","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B108","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10840-007-9088-y","article-title":"Catheter ablation of atrial fibrillation in patients with hyperthyroidism","volume":"18","author":"Ma","year":"2007","journal-title":"J Interv Card Electrophysiol"},{"key":"2026080923265475000_euy051-B109","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1253\/circj.CJ-12-0340","article-title":"Prevalence and influence of hyperthyroidism on the long-term outcome of catheter ablation for drug-refractory atrial fibrillation","volume":"76","author":"Machino","year":"2012","journal-title":"Circ J"},{"key":"2026080923265475000_euy051-B110","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.hrthm.2015.06.004","article-title":"History of hyperthyroidism and long-term outcome of catheter ablation of drug-refractory atrial fibrillation","volume":"12","author":"Wongcharoen","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026080923265475000_euy051-B111","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/clc.22427","article-title":"Benefit of anticoagulation therapy in hyperthyroidism-related atrial fibrillation","volume":"38","author":"Chan","year":"2015","journal-title":"Clin Cardiol"},{"key":"2026080923265475000_euy051-B112","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B113","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.STR.19.1.15","article-title":"Stroke in thyrotoxicosis with atrial fibrillation","volume":"19","author":"Petersen","year":"1988","journal-title":"Stroke"},{"key":"2026080923265475000_euy051-B114","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjmed.2014.07.014","article-title":"History of thyroid disorders in relation to clinical outcomes in atrial fibrillation","volume":"128","author":"Bruere","year":"2015","journal-title":"Am J Med"},{"key":"2026080923265475000_euy051-B115","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/0002-9149(89)90142-2","article-title":"Cardiac arrhythmias and heart rate in hyperthyroidism","volume":"63","author":"von Olshausen","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B116","first-page":"1.","article-title":"QT prolongation due to Graves' disease","volume":"2017","author":"Kulairi","year":"2017","journal-title":"Case Rep Cardiol"},{"key":"2026080923265475000_euy051-B117","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000437225","article-title":"Unusual manifestation of Graves\u2019 disease: ventricular fibrillation","volume":"4","author":"Kobayashi","year":"2015","journal-title":"Eur Thyroid J"},{"key":"2026080923265475000_euy051-B118","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jjcc.2012.05.012","article-title":"Atrioventricular block in patients with thyroid dysfunction: prognosis after treatment with hormone supplementation or antithyroid medication","volume":"60","author":"Ozcan","year":"2012","journal-title":"J Cardiol"},{"key":"2026080923265475000_euy051-B119","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1253\/jcj.59.824","article-title":"Hyperthyroidism complicated with sick sinus syndrome","volume":"59","author":"Namura","year":"1995","journal-title":"Jpn Circ J"},{"key":"2026080923265475000_euy051-B120","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0043-105275","article-title":"Prevalence of cardiac arrhythmias in hypothyroid and euthyroid patients","volume":"49","author":"Kannan","year":"2017","journal-title":"Horm Metab Res"},{"key":"2026080923265475000_euy051-B121","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1445-5994.1976.tb03294.x","article-title":"Recurrent ventricular tachycardia in hypothyroidism","volume":"6","author":"Lim","year":"1976","journal-title":"Aust N Z J Med"},{"key":"2026080923265475000_euy051-B122","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.0954-6820.1983.tb03724.x","article-title":"Long QT interval and ventricular tachycardia of \u201ctorsade de pointe\u201d type in hypothyroidism","volume":"213","author":"Fredlund","year":"1983","journal-title":"Acta Med Scand"},{"key":"2026080923265475000_euy051-B123","first-page":"224","article-title":"Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism","volume":"58","author":"Kukla","year":"2003","journal-title":"Kardiol Pol"},{"key":"2026080923265475000_euy051-B124","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00000441-200603000-00008","article-title":"Severe primary hypothyroidism manifesting with torsades de pointes","volume":"331","author":"Schenck","year":"2006","journal-title":"Am J Med Sci"},{"key":"2026080923265475000_euy051-B125","doi-asserted-by":"crossref","first-page":"bcr1220115306.","DOI":"10.1136\/bcr.12.2011.5306","article-title":"Severe primary hypothyroidism presenting with torsades de pointes","volume":"2012","author":"Kandan","year":"2012","journal-title":"BMJ Case Rep"},{"key":"2026080923265475000_euy051-B126","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1540-8167.2008.01154.x","article-title":"When an ICD is not the answer\u2026 Hypothyroidism-induced cardiomyopathy and torsades de pointes","volume":"19","author":"Ellis","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265475000_euy051-B127","first-page":"234","article-title":"Torsade de pointes ventricular tachycardia in a hypothyroid patient treated with propafenone","volume":"3","author":"Rosengarten","year":"1987","journal-title":"Can J Cardiol"},{"key":"2026080923265475000_euy051-B128","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/europace\/euu194","article-title":"EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias","volume":"16","author":"Pedersen","year":"2014","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B129","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCEP.113.001058","article-title":"Subclinical hypothyroidism: a reversible cause of complete loss of ventricular lead capture","volume":"7","author":"Esposito","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265475000_euy051-B130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1540-8159.1980.tb05580.x","article-title":"Exit block in myxedema, treated effectively by thyroid hormone therapy","volume":"3","author":"Schlesinger","year":"1980","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B131","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1540-8159.2008.01241.x","article-title":"Atrial lead dysfunction: an unusual feature of hypothyroidism","volume":"31","author":"Patton","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B132","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1378\/chest.70.5.677","article-title":"Unusually high pacemaker threshold in severe myxedema. Decrease with thyroid hormone therapy","volume":"70","author":"Basu","year":"1976","journal-title":"Chest"},{"key":"2026080923265475000_euy051-B133","first-page":"1859","article-title":"Disorders of intra-cardiac conduction and hypothyroidism in adults. A systematic study of 42 cases","volume":"4","author":"Lardoux","year":"1975","journal-title":"Nouv Presse Med"},{"key":"2026080923265475000_euy051-B134","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1540-8159.1999.tb06823.x","article-title":"Possible involvement of hypothyroidism as a cause of lithium-indiced sinus node dysfunction","volume":"22","author":"Numata","year":"1999","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B135","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0025-7753(03)73747-6","article-title":"Reversible sick sinus syndrome and hypothyroidism due to lithium","volume":"120","author":"Blanco","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"2026080923265475000_euy051-B136","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-8703(51)90026-9","article-title":"Complete auriculoventricular block in myxedema with reversion to normal sinus rhythm on thyroid therapy","volume":"41","author":"Schantz","year":"1951","journal-title":"Am Heart J"},{"key":"2026080923265475000_euy051-B137","doi-asserted-by":"crossref","first-page":"6.","DOI":"10.1186\/s13044-015-0018-2","article-title":"Second degree AV block and severely impaired contractility in cardiac myxedema: a case report","volume":"8","author":"Chatzitomaris","year":"2015","journal-title":"Thyroid Res"},{"key":"2026080923265475000_euy051-B138","first-page":"239","article-title":"Complete atrioventricular block presenting with syncope caused by severe hypothyroidism","volume":"3","author":"Seol","year":"2012","journal-title":"Cardiol Res"},{"key":"2026080923265475000_euy051-B139","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03086119","article-title":"Hypothyroidism as the cause of atrioventricular block in an elderly patient","volume":"16","author":"Schoenmakers","year":"2008","journal-title":"Neth Heart J"},{"key":"2026080923265475000_euy051-B140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1540-8159.2006.00284.x","article-title":"A case of transient 2: 1 atrioventricular block, resolved by thyroxine supplementation for subclinical hypothyroidism","volume":"29","author":"Nakayama","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B141","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/europace\/eut206","article-title":"2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"15","author":"Brignole","year":"2013","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B142","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5603\/EP.2015.0025","article-title":"Amiodarone and the thyroid","volume":"66","author":"Jabrocka-Hybel","year":"2015","journal-title":"Endokrynol Pol"},{"key":"2026080923265475000_euy051-B143","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080923265475000_euy051-B144","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet"},{"key":"2026080923265475000_euy051-B145","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","article-title":"Prescribing amiodarone an evidence-based review of clinical indications","volume":"298","author":"Vassallo","year":"2007","journal-title":"JAMA"},{"key":"2026080923265475000_euy051-B146","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical Utility of TSH Receptor Antibodies","volume":"98","author":"Barbesino","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080923265475000_euy051-B147","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"2026080923265475000_euy051-B148","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-17-0018","article-title":"The clinical value of regular thyroid function tests during amiodarone treatment","volume":"177","author":"Benjamens","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2026080923265475000_euy051-B149","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B150","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","article-title":"Adverse effects of low dose amiodarone: a meta-analysis","volume":"30","author":"Vorperian","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B151","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.amjmed.2007.04.022","article-title":"Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation","volume":"120","author":"Batcher","year":"2007","journal-title":"Am J Med"},{"key":"2026080923265475000_euy051-B152","first-page":"180","article-title":"Amiodarone-induced thyroid dysfunction","volume":"95","author":"Ross","year":"2005","journal-title":"S Afr Med J"},{"key":"2026080923265475000_euy051-B153","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2011.04087.x","article-title":"Determinants and outcome of amiodarone-associated thyroid dysfunction","volume":"75","author":"Ahmed","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026080923265475000_euy051-B154","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1253\/circj.72.102","article-title":"Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators","volume":"72","author":"Lee","year":"2008","journal-title":"Circ J"},{"key":"2026080923265475000_euy051-B155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.joa.2016.03.008","article-title":"Risk factors for amiodarone-induced thyroid dysfunction in Japan","volume":"32","author":"Kinoshita","year":"2016","journal-title":"J Arrhythm"},{"key":"2026080923265475000_euy051-B156","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1253\/jcj.65.958","article-title":"Amiodarone-induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan","volume":"65","author":"Shiga","year":"2001","journal-title":"Jpn Circ J"},{"key":"2026080923265475000_euy051-B157","first-page":"7","article-title":"Amiodarone induced thyrotoxicosis\u2014fluctuating RVOT and LV scar VT","volume":"5","author":"Pillarisetti","year":"2013","journal-title":"J Atr Fibrillation"},{"key":"2026080923265475000_euy051-B158","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1253\/circj.CJ-12-1615","article-title":"Chronic amiodarone therapy impairs the function of the superior sinoatrial node in patients with atrial fibrillation","volume":"77","author":"Mun","year":"2013","journal-title":"Circ J"},{"key":"2026080923265475000_euy051-B159","first-page":"110","article-title":"Severe amiodarone-induced bradycardia conceals sick sinus syndrome: case report","volume":"120","author":"Cracana","year":"2016","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"2026080923265475000_euy051-B160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0735-1097(02)02709-2","article-title":"Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction","volume":"41","author":"Essebag","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B161","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/TCRM.S96606","article-title":"Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases","volume":"12","author":"Czarnywojtek","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"2026080923265475000_euy051-B162","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.eupc.2003.11.002","article-title":"Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias","volume":"6","author":"Hermida","year":"2004","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B163","author":"UK Guidelines for the Use of Thyroid Function Tests","year":"2002"},{"key":"2026080923265475000_euy051-B164","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejim.2016.04.012","article-title":"Short-term amiodarone treatment for atrial fibrillation after catheter ablation induces a transient thyroid dysfunction: results from the placebo-controlled, randomized AMIO-CAT trial","volume":"33","author":"Diederichsen","year":"2016","journal-title":"Eur J Intern Med"},{"key":"2026080923265475000_euy051-B165","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11739-014-1140-1","article-title":"Amiodarone-related thyroid dysfunction","volume":"9","author":"Hudzik","year":"2014","journal-title":"Intern Emerg Med"},{"key":"2026080923265475000_euy051-B166","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0032-1306294","article-title":"High incidence of cardiovascular complications in pheochromocytoma","volume":"44","author":"Zelinka","year":"2012","journal-title":"Horm Metab Res"},{"key":"2026080923265475000_euy051-B167","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of phaeochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J Hypertens"},{"key":"2026080923265475000_euy051-B168","first-page":"925","article-title":"Influence of alpha-adrenergic blockade on ventricular arrhythmias, QTc interval and heart rate variability in phaeochromocytoma","volume":"9","author":"Dabrowska","year":"1995","journal-title":"J Hum Hypertens"},{"key":"2026080923265475000_euy051-B169","doi-asserted-by":"crossref","first-page":"509.","DOI":"10.1136\/heartjnl-2012-303311","article-title":"Pheochromocytoma presenting with bidirectional ventricular tachycardia","volume":"99","author":"Traykov","year":"2013","journal-title":"Heart"},{"key":"2026080923265475000_euy051-B170","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ecl.2006.09.014","article-title":"Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma","volume":"35","author":"Brouwers","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2026080923265475000_euy051-B171","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopha.2009.09.014","article-title":"Cardiovascular complications in patients with pheochromocytoma: a mini-review","volume":"64","author":"Galetta","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"2026080923265475000_euy051-B172","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1524-6175.2002.01452.x","article-title":"Pheochromocytoma","volume":"4","author":"Manger","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026080923265475000_euy051-B173","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF03015489","article-title":"Hypertension and tachycardia during adrenal manipulation","volume":"42","author":"Tewari","year":"1995","journal-title":"Can J Anaesth"},{"key":"2026080923265475000_euy051-B174","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"key":"2026080923265475000_euy051-B175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000375163","article-title":"Treatment factors that influence mortality in acromegaly","volume":"103","author":"McCabe","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2026080923265475000_euy051-B176","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080923265475000_euy051-B177","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080923265475000_euy051-B178","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/ERC-16-0106","article-title":"Mortality in acromegaly: a 20-year follow-up study","volume":"23","author":"Ritvonen","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"2026080923265475000_euy051-B179","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1210\/jc.2004-0821","article-title":"Long-term outcome of patients with acromegaly and congestive heart failure","volume":"89","author":"Bihan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080923265475000_euy051-B180","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1210\/jc.2015-2675","article-title":"Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort","volume":"100","author":"dos Santos Silva","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080923265475000_euy051-B181","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2265.2001.01319.x","article-title":"Occurrence of ventricular late potentials in patients with active acromegaly","volume":"55","author":"Herrmann","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026080923265475000_euy051-B182","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-8703(80)90277-X","article-title":"Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients","volume":"100","author":"Lie","year":"1980","journal-title":"Am Heart J"},{"key":"2026080923265475000_euy051-B183","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.CIR.99.11.1426","article-title":"Cell death in acromegalic cardiomyopathy","volume":"99","author":"Frustaci","year":"1999","journal-title":"Circulation"},{"key":"2026080923265475000_euy051-B184","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1378\/chest.102.4.1204","article-title":"Acromegalic cardiomyopathy. Left ventricular filling and hypertrophy in active and surgically treated disease","volume":"102","author":"Rossi","year":"1992","journal-title":"Chest"},{"key":"2026080923265475000_euy051-B185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000095530","article-title":"Acromegaly and the cardiovascular system","volume":"83","author":"Lombardi","year":"2006","journal-title":"Neuroendocrinology"},{"key":"2026080923265475000_euy051-B186","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2003-0009","article-title":"Cardiovascular function in acromegaly","volume":"24","author":"Clayton","year":"2003","journal-title":"Endocr Rev"},{"key":"2026080923265475000_euy051-B187","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/oxfordjournals.qjmed.a068078","article-title":"Acromegalic heart disease: influence of treatment of the acromegaly on the heart","volume":"62","author":"Hayward","year":"1987","journal-title":"Q J Med"},{"key":"2026080923265475000_euy051-B188","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.eurheartj.a060047","article-title":"Arrhythmia profile in acromegaly","volume":"13","author":"Kahaly","year":"1992","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B189","first-page":"243","article-title":"Electrocardiogram in endocrine and metabolic disorders","volume":"8","author":"Surawicz","year":"1977","journal-title":"Cardiovasc Clin"},{"key":"2026080923265475000_euy051-B190","first-page":"326","article-title":"Heart disease in acromegaly. Study of 27 patients","volume":"107","author":"Marin","year":"1996","journal-title":"Med Clin (Barc)"},{"key":"2026080923265475000_euy051-B191","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/hrt.62.3.185","article-title":"Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle","volume":"62","author":"Rodrigues","year":"1989","journal-title":"Br Heart J"},{"key":"2026080923265475000_euy051-B192","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijcard.2004.12.010","article-title":"Late potentials and ventricular arrhythmias in acromegaly","volume":"104","author":"Maffei","year":"2005","journal-title":"Int J Cardiol"},{"key":"2026080923265475000_euy051-B193","first-page":"287","article-title":"Sudden cardiac death in acromegaly. Anatomopathological observation of a case","volume":"89","author":"Matturri","year":"1998","journal-title":"Minerva Med"},{"key":"2026080923265475000_euy051-B194","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1378\/chest.72.4.495","article-title":"Dysrhythmias and sudden death in acromegalic heart disease. A clinicopathologic study","volume":"72","author":"Rossi","year":"1977","journal-title":"Chest"},{"key":"2026080923265475000_euy051-B195","first-page":"830 e9","article-title":"Acromegalic cardiomyopathy with malignant arrhythmogenic pattern successfully treated with mechanical circulatory support and heart transplantation","volume":"33","author":"Doimo","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026080923265475000_euy051-B196","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12020-012-9828-3","article-title":"QT dispersion in patients with acromegaly","volume":"43","author":"Unubol","year":"2013","journal-title":"Endocrine"},{"key":"2026080923265475000_euy051-B197","doi-asserted-by":"crossref","first-page":"428","DOI":"10.20344\/amp.4966","article-title":"The evaluation of QT intervals during diagnosis and after follow-up in acromegaly patients","volume":"27","author":"Baser","year":"2014","journal-title":"Acta Med Port"},{"key":"2026080923265475000_euy051-B198","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11102-016-0749-7","article-title":"Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naive acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment","volume":"19","author":"Warszawski","year":"2016","journal-title":"Pituitary"},{"key":"2026080923265475000_euy051-B199","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF03344070","article-title":"Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study","volume":"25","author":"Lombardi","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"2026080923265475000_euy051-B200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-12-0596","article-title":"Treatment with GH receptor antagonist in acromegaly: effect on cardiac arrhythmias","volume":"168","author":"Auriemma","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2026080923265475000_euy051-B201","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J Endocrinol Metab"},{"key":"2026080923265475000_euy051-B202","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.62.4.529","article-title":"Growth deceleration patterns in children with constitutional short statue: an aid to diagnosis","volume":"62","author":"Horner","year":"1978","journal-title":"Pediatrics"},{"key":"2026080923265475000_euy051-B203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11102-006-0416-5","article-title":"Hypopituitarism","volume":"9","author":"Ascoli","year":"2006","journal-title":"Pituitary"},{"key":"2026080923265475000_euy051-B204","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s40618-014-0142-1","article-title":"Evaluation of long-term pituitary functions in patients with severe ventricular arrhythmia: a pilot study","volume":"37","author":"Simsek","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"2026080923265475000_euy051-B205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1442-200X.1999.t01-1-01000.x","article-title":"Atrioventricular block in a patient with growth hormone deficiency during growth hormone therapy","volume":"41","author":"Okada","year":"1999","journal-title":"Pediatr Int"},{"key":"2026080923265475000_euy051-B206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am J Surg"},{"key":"2026080923265475000_euy051-B207","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3803\/EnM.2016.31.4.567","article-title":"Cardiac dysfunction in association with increased inflammatory markers in primary aldosteronism","volume":"31","author":"Lim","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2026080923265475000_euy051-B208","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.hrthm.2008.02.025","article-title":"The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias","volume":"5","author":"Iravanian","year":"2008","journal-title":"Heart Rhythm"},{"key":"2026080923265475000_euy051-B209","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ajh.2010.169","article-title":"Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment","volume":"23","author":"Sechi","year":"2010","journal-title":"Am J Hypertens"},{"key":"2026080923265475000_euy051-B210","doi-asserted-by":"crossref","first-page":"168.","DOI":"10.3389\/fendo.2014.00168","article-title":"Aldosterone and the heart: still an unresolved issue?","volume":"5","author":"Catena","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026080923265475000_euy051-B211","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.recesp.2010.10.015","article-title":"Update: systemic Diseases and the Cardiovascular System (II). The endocrine system and the heart: a review","volume":"64","author":"Rhee","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"2026080923265475000_euy051-B212","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B213","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11906-012-0256-9","article-title":"Aldosterone in heart disease","volume":"14","author":"Mihailidou","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"2026080923265475000_euy051-B214","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tem.2012.09.004","article-title":"Aldosterone and cardiovascular disease: the heart of the matter","volume":"24","author":"He","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"2026080923265475000_euy051-B215","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1440-1681.2001.03523.x","article-title":"New perspectives on the role of aldosterone excess in cardiovascular disease","volume":"28","author":"Stowasser","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2026080923265475000_euy051-B216","doi-asserted-by":"crossref","first-page":"e004667","DOI":"10.1161\/CIRCEP.116.004667","article-title":"Electrophysiology of hypokalemia and hyperkalemia","volume":"10","author":"Weiss","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265475000_euy051-B217","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/HYPERTENSIONAHA.116.08956","article-title":"Arterial hypertension, atrial fibrillation, and hyperaldosteronism: the triple trouble","volume":"69","author":"Seccia","year":"2017","journal-title":"Hypertension"},{"key":"2026080923265475000_euy051-B218","first-page":"CS174","article-title":"Life-threatening arrhythmia caused by primary aldosteronism","volume":"15","author":"Zelinka","year":"2009","journal-title":"Med Sci Monit"},{"key":"2026080923265475000_euy051-B219","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(00)04439-1","article-title":"Conn's syndrome and atrial fibrillation","volume":"357","author":"Porodko","year":"2001","journal-title":"Lancet"},{"key":"2026080923265475000_euy051-B220","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/1470320309342734","article-title":"Atrial fibrillation in primary aldosteronism","volume":"10","author":"Watson","year":"2009","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026080923265475000_euy051-B221","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080923265475000_euy051-B222","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","article-title":"Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry","volume":"94","author":"Born-Frontsberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080923265475000_euy051-B223","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B224","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/000331970205300415","article-title":"Adrenal adenoma presenting with torsade de pointes\u2014a case report","volume":"53","author":"Sade","year":"2002","journal-title":"Angiology"},{"key":"2026080923265475000_euy051-B225","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9149(96)00378-5","article-title":"Hyperaldosteronism and sudden cardiac death","volume":"78","author":"Geist","year":"1996","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B226","first-page":"85","article-title":"Adrenal adenoma presenting with ventricular fibrillation","volume":"32","author":"Aydin","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"2026080923265475000_euy051-B227","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2169\/internalmedicine.52.8794","article-title":"Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders","volume":"52","author":"Petramala","year":"2013","journal-title":"Intern Med"},{"key":"2026080923265475000_euy051-B228","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026080923265475000_euy051-B229","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"2026080923265475000_euy051-B230","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"key":"2026080923265475000_euy051-B231","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3909\/ricm0820","article-title":"Cardiac manifestations of adrenal insufficiency","volume":"17","author":"Schumaecker","year":"2016","journal-title":"Rev Cardiovasc Med"},{"key":"2026080923265475000_euy051-B232","first-page":"1.","article-title":"Addison's disease and dilated cardiomyopathy: a case report and review of the literature","volume":"2016","author":"Mozolevska","year":"2016","journal-title":"Case Rep Cardiol"},{"key":"2026080923265475000_euy051-B233","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/eje.0.1400425","article-title":"Regression of cardiac abnormalities after replacement therapy in Addison's disease","volume":"140","author":"Fallo","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2026080923265475000_euy051-B234","doi-asserted-by":"crossref","first-page":"e002919","DOI":"10.1161\/CIRCHEARTFAILURE.115.002919","article-title":"Reversible cardiomyopathy accompanied by secondary adrenal insufficiency","volume":"9","author":"Ikegami","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026080923265475000_euy051-B235","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4103\/0972-5229.171410","article-title":"Takotsubo cardiomyopathy in a patient with pituitary adenoma and secondary adrenal insufficiency","volume":"19","author":"Singh","year":"2015","journal-title":"Indian J Crit Care Med"},{"key":"2026080923265475000_euy051-B236","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/bmj.2.4684.860","article-title":"The effect of cortisone on the cardiogram in chronic adrenal insufficiency","volume":"2","author":"Somerville","year":"1950","journal-title":"Br Med J"},{"key":"2026080923265475000_euy051-B237","doi-asserted-by":"crossref","first-page":"1167 e1","DOI":"10.1016\/j.ajem.2008.12.001","article-title":"Lethal arrhythmia and corticosteroid insufficiency","volume":"27","author":"Nishizawa","year":"2009","journal-title":"Am J Emerg Med"},{"key":"2026080923265475000_euy051-B238","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2169\/internalmedicine.53.2726","article-title":"Long QT syndrome associated with adrenal insufficiency in a patient with isolated adrenocorticotropic hormone deficiency","volume":"53","author":"Kanamori","year":"2014","journal-title":"Intern Med"},{"key":"2026080923265475000_euy051-B239","first-page":"1539","article-title":"Inverted T waves in patient with Addisonian crisis","volume":"97","author":"Ozcan","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"2026080923265475000_euy051-B240","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00059-013-3983-z","article-title":"Type-1 Brugada-like ECG pattern induced by adrenal crisis","volume":"40","author":"Dogan","year":"2015","journal-title":"Herz"},{"key":"2026080923265475000_euy051-B241","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00380-015-0660-6","article-title":"Adrenal insufficiency causes life-threatening arrhythmia with prolongation of QT interval","volume":"31","author":"Komuro","year":"2016","journal-title":"Heart Vessels"},{"key":"2026080923265475000_euy051-B242","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jelectrocard.2012.10.007","article-title":"Extreme but not life-threatening QT interval prolongation? Take a closer look at the neck!","volume":"46","author":"Rentoukas","year":"2013","journal-title":"J Electrocardiol"},{"key":"2026080923265475000_euy051-B243","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/omcr\/omu030","article-title":"Primary hypoparathyroidism presenting with heart failure and ventricular fibrillation","volume":"2014","author":"\u00c7akerri","year":"2014","journal-title":"Oxf Med Case Reports"},{"key":"2026080923265475000_euy051-B244","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-0736(05)80092-5","article-title":"Serum calcium and the ECG in patients with primary hyperparathyroidism","volume":"27","author":"Lind","year":"1994","journal-title":"J Electrocardiol"},{"key":"2026080923265475000_euy051-B245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-8703(67)90154-8","article-title":"Cardiac manifestations of hyperparathyroidism, with presentation of a previously unreported arrhythmia","volume":"73","author":"Voss","year":"1967","journal-title":"Am Heart J"},{"key":"2026080923265475000_euy051-B246","first-page":"1115","article-title":"Bigeminal arrhythmia associated with hyperparathyroid crisis","volume":"138","author":"Chadli","year":"1988","journal-title":"Cmaj"},{"key":"2026080923265475000_euy051-B247","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1540-8159.2000.tb00842.x","article-title":"Ventricular tachycardia in a patient with primary hyperparathyroidism","volume":"23","author":"Chang","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B248","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0167-5273(02)00314-5","article-title":"Storms of ventricular tachyarrhythmias associated with primary hyperparathyroidism in a patient with dilated cardiomyopathy","volume":"87","author":"Kolb","year":"2003","journal-title":"Int J Cardiol"},{"key":"2026080923265475000_euy051-B249","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"key":"2026080923265475000_euy051-B250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF01658740","article-title":"The influence of surgery on the risk of death in patients with primary hyperparathyroidism","volume":"15","author":"Hedb\u00e4ck","year":"1991","journal-title":"World J Surg"},{"key":"2026080923265475000_euy051-B251","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-13-0293","article-title":"Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test","volume":"169","author":"Pepe","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2026080923265475000_euy051-B252","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/107424849900400408","article-title":"Viagra and cardiovascular disease","volume":"4","author":"Speakman","year":"1999","journal-title":"Cardiovasc Pharmacol Therapeut"},{"key":"2026080923265475000_euy051-B253","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.eupc.2004.01.005","article-title":"Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death","volume":"6","author":"Occhetta","year":"2004","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B254","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/pace.12369","article-title":"The influence of gender on heart rhythm disease","volume":"37","author":"Di Fusco","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B255","first-page":"783","article-title":"Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms","volume":"30","author":"Tadros","year":"2014","journal-title":"Can J Cardiol"},{"key":"2026080923265475000_euy051-B256","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/clc.21975","article-title":"Arrhythmias in women","volume":"35","author":"Curtis","year":"2012","journal-title":"Clin Cardiol"},{"key":"2026080923265475000_euy051-B257","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pharmthera.2010.04.002","article-title":"Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology","volume":"127","author":"Jonsson","year":"2010","journal-title":"Pharmacol Ther"},{"key":"2026080923265475000_euy051-B258","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.yjmcc.2010.06.005","article-title":"Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts","volume":"49","author":"Gaborit","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"2026080923265475000_euy051-B259","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/S0735-1097(02)02492-0","article-title":"Prevalence of male and female patterns of early ventricular repolarization in the normal ECG of males and females from childhood to old age","volume":"40","author":"Surawicz","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B260","doi-asserted-by":"crossref","first-page":"2590.","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs","volume":"270","author":"Makkar","year":"1993","journal-title":"JAMA"},{"key":"2026080923265475000_euy051-B261","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacep.2016.02.015","article-title":"Influence of oral progesterone administration on drug-induced qt interval lengthening: a randomized, double-blind, placebo-controlled crossover study","volume":"2","author":"Tisdale","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B262","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1161\/01.CIR.97.22.2237","article-title":"Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry","volume":"97","author":"Locati","year":"1998","journal-title":"Circulation"},{"key":"2026080923265475000_euy051-B263","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2006.09.054","article-title":"Long QT syndrome and pregnancy","volume":"49","author":"Seth","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B264","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0002-9149(92)90060-C","article-title":"Age at onset and gender of patients with different types of supraventricular tachycardias","volume":"70","author":"Rodriguez","year":"1992","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B265","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.amjcard.2005.11.041","article-title":"Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes","volume":"97","author":"Silversides","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B266","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2026080923265475000_euy051-B267","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2026080923265475000_euy051-B268","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1253\/circj.CJ-12-1036","article-title":"Stroke and thromboembolism in atrial fibrillation","volume":"76","author":"Pisters","year":"2012","journal-title":"Circ J"},{"key":"2026080923265475000_euy051-B269","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/STROKEAHA.115.009371","article-title":"Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study","volume":"46","author":"Overvad","year":"2015","journal-title":"Stroke"},{"key":"2026080923265475000_euy051-B270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jacc.2015.10.080","article-title":"Effect of diabetes and glycemic control on ischemic stroke risk in AF patients: aTRIA study","volume":"67","author":"Ashburner","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080923265475000_euy051-B271","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1378\/chest.14-2096","article-title":"The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the Loire Valley atrial fibrillation project","volume":"147","author":"Lip","year":"2015","journal-title":"Chest"},{"key":"2026080923265475000_euy051-B272","doi-asserted-by":"crossref","first-page":"be91398","DOI":"10.1371\/journal.pone.0091398","article-title":"Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillation","volume":"9","author":"Lega","year":"2014","journal-title":"PLoS One"},{"key":"2026080923265475000_euy051-B273","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT(2)R(2) score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"2026080923265475000_euy051-B274","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"2026080923265475000_euy051-B275","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1253\/circj.CJ-09-0708","article-title":"High-normal thyroid function and risk of recurrence of atrial fibrillation after catheter ablation","volume":"74","author":"Tang","year":"2010","journal-title":"Circ J"},{"key":"2026080923265475000_euy051-B276","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.amjcard.2015.09.028","article-title":"Impact of free thyroxine on the outcomes of left atrial ablation procedures","volume":"116","author":"Sousa","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B277","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10840-017-0234-x","article-title":"Prevalence of right atrial non-pulmonary vein triggers in atrial fibrillation patients treated with thyroid hormone replacement therapy","volume":"49","author":"Kim","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"2026080923265475000_euy051-B278","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5603\/CJ.a2016.0029","article-title":"Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis","volume":"23","author":"Wang","year":"2016","journal-title":"Cardiol J"},{"key":"2026080923265475000_euy051-B279","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/jce.12140","article-title":"Catheter ablation of paroxysmal atrial fibrillation in patients with previous amiodarone-induced hyperthyroidism: a case-control study","volume":"24","author":"Mikhaylov","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923265475000_euy051-B280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/erd.10.80","article-title":"From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems","volume":"8","author":"Diemberger","year":"2011","journal-title":"Expert Rev Med Devices"},{"key":"2026080923265475000_euy051-B281","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1586\/17434440.2013.811837","article-title":"From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction","volume":"10","author":"Mazzotti","year":"2013","journal-title":"Expert Rev Med Devices"},{"key":"2026080923265475000_euy051-B282","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjcard.2012.11.052","article-title":". Predictors of mortality in patients with cardiovascular implantable electronic device infections","volume":"111","author":"Habib","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B283","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2459\/JCM.0000000000000008","article-title":"Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent","volume":"15","author":"De Maria","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026080923265475000_euy051-B284","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehv060","article-title":"Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment","volume":"36","author":"Nielsen","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080923265475000_euy051-B285","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifyingprognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026080923265475000_euy051-B286","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ejhf.509","article-title":"Cardiac device therapy in patients with left ventricular dysfunction and heart failure: \u2032real-world\u2032 data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital)","volume":"18","author":"Boriani","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026080923265475000_euy051-B287","doi-asserted-by":"crossref","first-page":"e004132.","DOI":"10.1161\/CIRCEP.116.004132","article-title":"Diabetes and outcomes of cardiac resynchronization with implantable cardioverter defibrillator therapy in older patients with heart failure","volume":"9","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265475000_euy051-B288","doi-asserted-by":"crossref","first-page":"e004463.","DOI":"10.1161\/CIRCEP.116.004463","article-title":"The impact of diabetes and comorbidities on the outcome of heart failure patients treated with cardiac resynchronization therapy: implications for patient management","volume":"9","author":"Boriani","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923265475000_euy051-B289","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12872-015-0018-0","article-title":"Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis","volume":"15","author":"Sun","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"2026080923265475000_euy051-B290","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2337\/dc06-2035","article-title":"Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure","volume":"30","author":"Hoppe","year":"2007","journal-title":"Diabetes Care"},{"key":"2026080923265475000_euy051-B291","doi-asserted-by":"crossref","first-page":"111-121.","DOI":"10.7326\/M13-1787","article-title":"Effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in subgroups a systematic review","volume":"160","author":"Earley","year":"2014","journal-title":"Ann Intern Med"},{"key":"2026080923265475000_euy051-B292","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1586\/14779072.2015.1059276","article-title":"Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death","volume":"13","author":"Shahreyar","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026080923265475000_euy051-B293","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/europace\/euq316","article-title":"Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management","volume":"12","author":"Braunschweig","year":"2010","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B294","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/europace\/euv202","article-title":"Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society","volume":"17","author":"Boriani","year":"2015","journal-title":"Europace"},{"key":"2026080923265475000_euy051-B295","first-page":"47","article-title":"Thyrotoxicosis and the cardiovascular system","volume":"30","author":"Roffi","year":"2005","journal-title":"Minerva Endocrinol"},{"key":"2026080923265475000_euy051-B296","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1046\/j.1460-9592.2001.01827.x","article-title":"Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice","volume":"24","author":"Marketou","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080923265475000_euy051-B297","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.amjcard.2015.01.559","article-title":"Association of hypothyroidism with adverse events in patients with heart failure receiving cardiac resynchronization therapy","volume":"115","author":"Sharma","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026080923265475000_euy051-B298","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ejhf.42","article-title":"The effect of thyroid function on clinical outcome in patients with heart failure","volume":"16","author":"Chen","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080923265475000_euy051-B299","author":"NCT 02650479"},{"key":"2026080923265475000_euy051-B300","author":"Haugaard"},{"key":"2026080923265475000_euy051-B301","author":"Rosenqvist"},{"key":"2026080923265475000_euy051-B302","author":"Giesecke"},{"key":"2026080923265475000_euy051-B303","author":"Kerstens"},{"key":"2026080923265475000_euy051-B304","author":"Zhang"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/20\/6\/895\/70576759\/europace_20_6_895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/20\/6\/895\/70576759\/europace_20_6_895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:38:33Z","timestamp":1786333113000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/20\/6\/895\/4939247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":304,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euy051","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,3,16]]}}}